Vrk2tm1d(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Vrk2tm1d(KOMP)Wtsi |
Name: |
vaccinia related kinase 2; targeted mutation 1d, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6391392 |
Synonyms: |
VRK2KO |
Gene: |
Vrk2 Location: Chr11:26421398-26544006 bp, - strand Genetic Position: Chr11, 15.94 cM
|
Alliance: |
Vrk2tm1d(KOMP)Wtsi page
|
IMPC: |
Vrk2 gene page |
|
Germline Transmission: |
Earliest citation of germline transmission:
J:277696
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 26499770 of Chromosome 11 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 26500513. The critical exon(s) is/are thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:277696)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Vrk2 Mutation: |
35 strains or lines available
|
|
Original: |
J:277696 Lee J, et al., Vaccinia-related kinase 2 plays a critical role in microglia-mediated synapse elimination during neurodevelopment. Glia. 2019 Sep;67(9):1667-1679 |
All: |
1 reference(s) |
|